Green tea extract taken over 3 years was well tolerated but had no significant effects, according to the results of a large randomized controlled trial.
Patients with metastatic disease experienced a progression-free survival benefit on maintenance therapy but worse toxicity and no overall survival advantage compared with those on active monitoring.